- NEWS
- Correction 12 August 2020
Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 584, 333-334 (2020)
doi: https://doi.org/10.1038/d41586-020-02360-y
Updates & Corrections
-
Correction 12 August 2020: An earlier version of this story incorrectly said that the median price for antibody therapies in the United States is US$15,000–$200,000 per treatment. In fact, this is the cost per year of treatment.